Merck Competitors

6MK Stock  EUR 103.20  0.20  0.19%   
Merck competes with Abbott Laboratories, Advanced Micro, Philip Morris, Amgen, and Hong Kong; as well as few others. The company operates under Metals & Mining sector and is part of Materials industry. Analyzing Merck competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Merck to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Merck Correlation with its peers.

Merck vs FREEPORT MCMORAN Correlation

Poor diversification

The correlation between Merck Co and FPMB is 0.79 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Merck Co and FPMB in the same portfolio, assuming nothing else is changed.

Moving together with Merck Stock

  0.764I1 Philip Morris InternPairCorr
  0.63AMG Amgen IncPairCorr

Moving against Merck Stock

  0.61DBPD Xtrackers ShortDAXPairCorr
  0.57HK2C Hong Kong ExchangesPairCorr
  0.51ABL Abbott LaboratoriesPairCorr
  0.46AMD Advanced Micro DevicesPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
102.24103.88105.52
Details
Intrinsic
Valuation
LowRealHigh
92.88105.53107.17
Details
Naive
Forecast
LowNextHigh
108.13109.78111.42
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
80.7090.46100.23
Details

Merck Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Merck and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Merck and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Merck does not affect the price movement of the other competitor.

High positive correlations

FPMBDP4B
FPMB4I1
HK2CAMD
DP4B4I1
AMG4I1
HK2CABL
  

High negative correlations

4I1ABL
FPMBABL
DP4BHK2C
FPMBHK2C
DP4BABL
AMGABL

Risk-Adjusted Indicators

There is a big difference between Merck Stock performing well and Merck Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Merck's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Merck Competitive Analysis

The better you understand Merck competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Merck's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Merck's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6MK ABL AMD 4I1 AMG HK2C DP4B FPMB
 0.19 
 103.20 
Merck
 1.51 
 93.82 
Abbott
 8.28 
 176.60 
Advanced
 0.18 
 154.12 
Philip
 4.13 
 324.15 
Amgen
 0.00 
 45.31 
Hong
 0.00 
 1,959 
DP4B
 0.00 
 44.35 
FREEPORT
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Net Asset
EBITDA
Current Valuation
Price To Book
Total Asset
Retained Earnings
Last Dividend Paid
Market Capitalization
Price To Earnings To Growth
Price To Sales
Net Income
Cash Flow From Operations
Annual Yield
Total Debt
Revenue
Working Capital
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Merck Competition Performance Charts

Five steps to successful analysis of Merck Competition

Merck's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Merck in relation to its competition. Merck's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Merck in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Merck's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Merck, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Merck position

In addition to having Merck in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Books Thematic Idea Now

Books
Books Theme
Companies involved in publishing of books, newspapers, periodicals and other mass publications. The Books theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Books Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Merck Stock

Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.